Pathological analysis revealed that four out of the five Rb+/−7−/− tumor lesions were medullary thyroid carcinomas, suggesting that loss of E2F7 aggravates the malignant progression of Rb-deficient thyroid tumors (Figure 3E,F). The gene discussed is E2F7; the disease is medullary thyroid gland carcinoma.